In vitro comparison of renal handling and uptake of two somatostatin receptor-specific peptides labeled with indium-111

Annals of Nuclear Medicine

Volumn 22, Issue 10, 2008, Pages 859-867

  Trejtnar, Frantisek ^a   Novy, Zbynek ^a   Petrik, Milos ^a   Laznickova, Alice ^a   Melicharova, Ludmila ^a   Vankova, Marie ^a   Laznicek, Milan ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Antitumor agents; Radiodiagnostics; Radiotheraphy; Renal elimination; Somatostatin analog

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID OCTREOTIDE[3 (1 NAPHTHYLALANINE)] INDIUM IN 111; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID OCTREOTIDE[3 TYROSINE 8 THREONINE] INDIUM IN 111; APROTININ; INDIUM CHLORIDE IN 111; LYSINE; MALEIC ACID; OCTREOTIDE; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG POTENCY; DRUG UPTAKE; ENDOCYTOSIS; IN VITRO STUDY; ISOTOPE LABELING; KIDNEY CELL; KIDNEY CLEARANCE; KIDNEY PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELLS, CULTURED; KIDNEY; MALE; METABOLIC CLEARANCE RATE; OCTREOTIDE; ORGANOMETALLIC COMPOUNDS; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; RECEPTORS, SOMATOSTATIN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

EID: 58249121617     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-008-0192-6     Document Type: Article

References (39)

1. A. Signore A. Annovazzi M. Chianelli F. Corsetti C. Van de Wiele R.N. Watherhouse 2001 Peptide radiopharmaceuticals for diagnosis and therapy Eur J Nucl Med 28 1555 1565
2. R.E. Weiner M.L. Thakur 2002 Radiolabeled peptides in the diagnosis and therapy of oncological diseases Appl Radiat Isot 57 749 763
3. F. Forrer R. Valkema D.J. Kwekkeboom M. de Jong E.P. Krenning 2007 Neuroendocrine tumors: peptide receptor radionuclide therapy Best Pract Res Clin Endocrinol Metab 21 111 129
4. 3]-octreotide: the Rotterdam experience with more than 1000 patients Eur J Nucl Med 20 716 731
5. 111In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy Cancer Res 58 437 441
6. 0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization? J Nucl Med 46 1561 1569
7. D. Wild J.S. Schmitt M. Ginj H.R. Macke B.F. Bernard E. Krenning 2003 DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals Eur J Nucl Med Mol Imaging 30 1338 1347
8. M. De Jong R. Valdema F. Jamar L.K. Kvols D.J. Kwekkeboom W.A. Breeman 2002 Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings Semin Nucl Med 32 133 140
9. 3]octreotate in patients with endocrine gastroenteropancreatic tumors J Clin Oncol 23 2754 2762
10. M. Van Essen E.P. Krenning M. De Jong R. Valkema D.J. Kwekkeboom 2007 Peptide receptor radionuclide therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours Acta Oncol 46 23 34
11. O.C. Boerman J.G. Wim F.H.M. Corstens 2001 Between the Scylla and Charybdis of peptide radionuclide therapy: hitting the tumor and saving the kidney Eur J Nucl Med 28 1447 1449
12. 90Y-DOTATOC Eur J Nucl Med 28 1552 1554
13. S. Moll V. Nickeleit J. Mueller-Brand F.P. Brunner H.R. Maecke M.J. Mihatsch 2001 A new cause of renal thrombotic microangiopathy: yttrium 90-DOTATOC internal radiotherapy Am J Kidney Dis 37 847 851
14. P.J. Hammond A.F. Wade M.E. Gwillian A.M. Peters M.J. Myers S.G. Gilbey 1993 Amino acid infusion blocks renal tubular uptake of indium-labelled somatostatin analogue Br J Cancer 67 1437 1439
15. M. De Jong E.J. Rolleman B.F. Bernard T.J. Visser W.H. Bakker W.A. Breeman 1996 Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo J Nucl Med 37 1388 1392
16. T.M. Behr D.M. Goldenberg W. Becker 1998 Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations Eur J Nucl Med 25 201 212
17. 111In-DTPA-octreotide J Nucl Med 46 1696 1700
18. M. Melis E.P. Krenning B.F. Bernard R. Barone T.J. Visser M. de Jong 2005 Localisation and mechanism of renal retention of radiolabelled somatostatin analogues Eur J Nucl Med Mol Imaging 32 1136 1143
19. E.J. Rolleman P.P. Kooij W.W. de Herder R. Valkema E.P. Krenning M. de Jong 2007 Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney Eur J Nucl Med Mol Imaging 34 1854 1860
20. 99mTc-MDP in the rat Pharm Pharmacol Lett 8 112 114
21. A. Heyrovsky 1956 A new method for the determination of inulin in plasma and urine Clin Chim Acta 1 470 474
22. A. Laznickova M. Laznicek J. Kvetina J. Drobnik 1986 Pharmacokinetics and plasma protein binding of two platinum cytostatics CHIP and CBDCA in rats Cancer Chemother Pharmacol 17 133 136
23. D.P. Jones G.B. Sundby K. Ormstad S. Orrenius 1979 Use of isolated kidney cells for study of drug metabolism Biochem Pharmacol 28 929 935
24. P.J. Boogaard G.J. Mulder J.F. Nagelkerke 1989 Isolated proximal tubular cells from rat kidney as an in vitro model for studies on nephrotoxicity: I. An improved method for preparation of proximal tubular cells and their functional characterization by alpha-methylglucose uptake Toxicol Appl Pharmacol 101 135 143
25. 99mTc-MAG3 via rat renal organic anion J Nucl Med 45 86 88
26. 111In-DTPA-conjugated peptides Nucl Med Biol 28 761 768
27. 111In-DTPA-D-Phe1-octreotide and 111In- DTPA-L-Phe1-octreotide in rats Eur J Drug Metab Pharmacokinet 27 37 43
28. M. Melis E.P. Krenning B.F. Bernard M. de Visser E. Rolleman M. de Jong 2007 Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: species and gender differences Nucl Med Biol 34 633 641
29. 99mTc-labeled peptides J Nucl Med 1 177 182
30. 3-octreotide in the rat kidneys Nucl Med Biol 31 231 239
31. 99mTc-demotate 1: biodistribution and elimination characteristics in rats Nucl Med Commun 26 549 554
32. 111In]DOTA-tate Eur J Nucl Med Mol Imaging 33 831 840
33. J.C. Reubi J.C. Schar B. Waser S. Wenger A. Heppeler J.S. Schmitt 2000 Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use Eur J Nucl Med 27 273 282
34. Q. Wang K. Graham T. Schauer T. Fietz A. Mohammed X. Liu 2004 Pharmacological properties of hydrophilic and lipophilic derivatives of octreotate Nucl Med Biol 31 21 30
35. J.R. Duncan T.M. Behr S.J. DeNardo 1997 Intracellular fate of radiometals J Nucl Med 38 829
36. R. Barone P. Van Der Smissen O. Devuyst V. Beaujean S. Pauwels P.J. Courtoy 2005 Endocytosis of the somatostatin analogue, octreotide, by the proximal tubule-derived opossum kidney (OK) cell line Kidney Int 67 969 976
37. E.I. Christensen R. Nielsen 2007 Role of megalin and cubilin in renal physiology and pathophysiology Rev Physiol Biochem Pharmacol 158 1 22
38. J.C. Reubi U. Horisberger U.E. Studer B. Waser J.A. Laissue 1993 Human kidney as target for somatostatin: high affinity receptors in tubules and vasa recta Clin Endocrinol Metab 77 1323 1328
39. 2 in tubules and glomeruli of human kidney Am J Physiol Renal Physiol 280 F457 F465